Maravai LifeSciences Holdings Inc (MRVI)
8.97
+0.17
(+1.93%)
USD |
NASDAQ |
May 03, 16:00
8.965
0.00 (0.00%)
After-Hours: 20:00
Maravai LifeSciences Holdings Cash from Investing (TTM): -122.31M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -122.31M |
| September 30, 2023 | -127.93M |
| June 30, 2023 | -118.25M |
| March 31, 2023 | -95.76M |
| December 31, 2022 | -267.61M |
| September 30, 2022 | -254.75M |
| June 30, 2022 | -130.27M |
| Date | Value |
|---|---|
| March 31, 2022 | -133.14M |
| December 31, 2021 | 105.66M |
| September 30, 2021 | 102.46M |
| June 30, 2021 | -26.26M |
| March 31, 2021 | -24.78M |
| December 31, 2020 | 6.068M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-267.61M
Minimum
Dec 2022
105.66M
Maximum
Dec 2021
-83.61M
Average
-118.25M
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
| ModivCare Inc | -42.29M |
| Dyadic International Inc | 7.450M |
| Enveric Biosciences Inc | 0.0117M |
| Monopar Therapeutics Inc | 4.928M |
| SeaStar Medical Holding Corp | -- |